As of 2025-05-22, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.16 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.11 CAD, the upside of BetterLife Pharma Inc is -243.50%.
Based on its market price of 0.11 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 243.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.16 - -0.16 | -0.16 | -243.50% |
| DDM - Stable | (0.60) - 14.08 | 6.74 | 6023.7% |
| DDM - Multi | (1.82) - 32.82 | (3.85) | -3596.1% |
| Market Cap (mil) | 14.24 |
| Beta | -0.16 |
| Outstanding shares (mil) | 129.46 |
| Enterprise Value (mil) | 15.08 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.73% |
| Cost of Debt | 5.00% |
| WACC | 5.61% |